tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Katie Tryhane, 1 are a HOLD (7.14%), 11 are a BUY (78.57%), 2 are a SELL (14.29%).
Analyst Katie Tryhane, carries an average stock price target met ratio of 68.75% that have a potential upside of 13.97% achieved within 341 days. Previously, Katie Tryhane worked at CREDIT SUISSE.
Katie Tryhane’s has documented 28 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 25-Aug-2022.
Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGS).
The best stock recommendation documented was for MRVI (MARAVAI LIFESCIENCES HOLDINGS) at 8/11/2021. The price target of $54 was fulfilled within 1 day with a profit of $4 (8%) receiving and performance score of 80.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Sep-2026
$340
$49.81 (17.16%)
$195
9 days ago
(28-Sep-2026)
27/29 (93.1%)
$45.41 (15.41%)
235
Buy Since 09-Jul-2025
$330
$39.81 (13.72%)
$320
12 days ago
(25-Sep-2026)
9/12 (75%)
$37.16 (12.69%)
200
Buy Since 06-Aug-2026
$322
$31.81 (10.96%)
$282
12 days ago
(25-Sep-2026)
1/2 (50%)
$29.16 (9.96%)
5
Buy Since 06-Nov-2025
$330
$39.81 (13.72%)
$220
12 days ago
(25-Sep-2026)
13/14 (92.86%)
$37.16 (12.69%)
53
Hold Since 07-Jun-2024
$295
$4.81 (1.66%)
$230
12 days ago
(25-Sep-2026)
11/11 (100%)
$2.16 (0.74%)
30
